Hemodynamic Responses of Stable Ischemic Heart Disease Patients to a Comedy Session

Hemodynamic Responses of Stable Ischemic Heart Disease Patients to a Comedy Session: Randomized Controlled Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02849067

Enrollment

Registered

2016-07-29

Start date

2015-05-25

Completion date

2019-12-30

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischaemic Heart Disease

Keywords

ischaemic heart disease, comedy session, laughter therapy

Brief summary

It is known that laughter can bring benefits in terms of physiological and psychological parameters, in addition to improving the individual's quality of life. However, the literature is still scarce as to the existence of studies investigating the effects of a comedy film specifically in hemodynamics.

Detailed description

Objective: To evaluate the effect of a comedy film session on the cardiac index, Systemic Vascular Resistance and Vascular Resistance Index Systemic in stable ischemic heart disease patients. Method: Randomized Clinical Trial. Patients will be coming from Ischemic Heart Disease clinic at the Hospital de Clínicas de Porto Alegre (HCPA), all in regular monitoring.

Interventions

OTHERGroup Treatment

Patients in this group will watch a comedy show that will will not exceed 30 minutes. This group will have until five patients.

OTHERGroup Control

patients in this group will watch a documentary that will not exceed 30 minutes. This will have until five patients

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

40 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Ages between 40 and 80 years * Both female and male * Diagnosis of ischemic heart disease by cardiac catheterization , with 50% lesion in at least one epicardial vessel

Exclusion criteria

* Participants enrolled in another Randomized Clinical trial * Autoimmune diseases * Valvulopathy with mechanical or biological cardiac prosthesis * Presence of pacemakers and implantable cardioverter * Left bundle branch block in the electrocardiogram (ECG) of 12 derivations * Severe lung disease * Depression or Bipolar Disorder * Atrial Chronic Fibrillation * Left ventricular dysfunction (ejection fraction \<45%) * Active Infection or neoplasia (not Basal cell carcinoma) * Chronic Renal Failure * Illiteracy and inability to understand the consent form

Design outcomes

Primary

Measure	Time frame	Description
Cardiography impedance	28 weeks	To assess the volumes and fluid passing through the chest at rest and during the exercise session will be used the Cardiography impedance device PhysioFlow, Enduro model (ManatecBiomedical, France).

Secondary

Measure	Time frame	Description
Humor	28 weeks	it will be used the Humor Scale of Brunel

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026